Cochrane Abstracts
Combination chemotherapy for primary treatment of high‐risk gestational trophoblastic tumour
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Combination Chemotherapy for Primary Treatment of High‐risk Gestational Trophoblastic Tumour." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434297/all/Combination_chemotherapy_for_primary_treatment_of_high‐risk_gestational_trophoblastic_tumour.
Combination chemotherapy for primary treatment of high‐risk gestational trophoblastic tumour. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434297/all/Combination_chemotherapy_for_primary_treatment_of_high‐risk_gestational_trophoblastic_tumour. Accessed March 20, 2025.
Combination chemotherapy for primary treatment of high‐risk gestational trophoblastic tumour. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434297/all/Combination_chemotherapy_for_primary_treatment_of_high‐risk_gestational_trophoblastic_tumour
Combination Chemotherapy for Primary Treatment of High‐risk Gestational Trophoblastic Tumour [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434297/all/Combination_chemotherapy_for_primary_treatment_of_high‐risk_gestational_trophoblastic_tumour.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Combination chemotherapy for primary treatment of high‐risk gestational trophoblastic tumour
ID - 434297
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434297/all/Combination_chemotherapy_for_primary_treatment_of_high‐risk_gestational_trophoblastic_tumour
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
